How Nextyn’s Expert Network Provided Actionable Competitive Intelligence for a Pharmaceutical Firm
Executive Summary
A leading pharmaceutical company was preparing to launch a new drug but faced intense competition from a rival firm’s upcoming product. The company needed real-time competitive intelligence to assess the competitor’s pricing strategy, market positioning, regulatory status, and potential impact on its own product launch.
To gain first-hand insights from industry insiders, the pharma company partnered with Nextyn’s Moderated Expert Calls Service to engage former executives, R&D specialists, and regulatory experts who had worked within the competitor’s ecosystem.
Key Actions Taken
- Conducted expert interviews with ex-employees, regulatory advisors, and healthcare analysts.
- Gathered insights on clinical trial progress, competitor pricing strategies, and distribution plans.
- Used expert intelligence to adjust pricing models and refine go-to-market strategies.
Outcome: The pharmaceutical company optimized its pricing and market entry approach, giving it an early advantage over the competitor’s product.
Client Challenges
- Limited access to internal competitor insights on clinical trial progress and regulatory approvals.
- Uncertainty about competitor’s pricing model and reimbursement strategies.
- Needed clarity on how doctors and hospitals were likely to adopt the rival drug.
- Regulatory risks and potential patent challenges from the competitor.
Without insider perspectives, the company risked being unprepared for competitor moves and losing early market share.
Nextyn’s Solution
Expert Call Execution and Intelligence Gathering
- Identified and engaged former employees from the competitor’s R&D, regulatory, and sales divisions.
- Moderated expert discussions focusing on:
- Competitor’s clinical trial outcomes and regulatory approval timeline.
- Price benchmarking against industry standards.
- Competitor’s marketing and sales strategy for prescribers and hospitals.
Competitive Strategy Recommendations
- Adjusted launch pricing and reimbursement positioning based on expert intelligence.
- Developed a counter-strategy for physician outreach and hospital engagement.
- Recommended regulatory strategies to preempt competitor challenges.
Impact & Results
- The company optimized its pricing model to undercut competitors while maintaining profitability.
- Sales team gained a first-mover advantage in targeting high-prescribing physicians.
- Adjusted marketing messaging to highlight differentiation from the rival drug.
- Identified regulatory loopholes that allowed for faster approvals and market penetration.
Why Nextyn?
- Extensive network of industry insiders and former executives for direct competitor intelligence.
- Proven expertise in pharmaceutical market research and product launch strategies.
- Confidential, compliance-driven expert call moderation for unbiased insights.
- Customized approach to competitor benchmarking and strategic positioning.
